FundingHealthcare & Life Sciences
Venomics AI raises $2.7M pre-seed for venom drug discovery
By Abha Lohia · Editor ·
Pre-SeedBengaluruFounded 2026
- Venomics AI is a Bengaluru biotech spun out of IISc, using venom biology, sequencing and AI to find therapeutic drug leads
- It closed a $2.7M pre-seed round, its first institutional funding, co-led by Speciale Invest and South Park Commons
- The money will grow its molecular dataset, called the Venom Atlas, and strengthen its AI and laboratory screening work
What happened
- Venomics AI raised $2.7M in its first institutional round.
- Speciale Invest and South Park Commons co-led, with Operators Studio joining.
- Funds go to a bigger molecular dataset and stronger lab screening.
- The firm is building the Venom Atlas, linking venom molecules to lab results.
Why it matters
- India's rich venom biodiversity is an under-used source of drug leads.
- Lab results feed back into AI predictions, tightening the discovery loop.
- It aims to be a home-grown platform for global therapeutic development.
The business
- IISc spin-out based in Bengaluru
- Combines venom biology, sequencing, AI and lab screening
- Builds the Venom Atlas dataset
- AI ranks candidate molecules
- Lab tests check the AI predictions
- Targets venom-derived therapeutic leads
The founders
VP
Vinay Prabhu
Co-founderWho put in money
- Speciale Invest Co-lead
- South Park Commons Co-lead
- Operators Studio Participant
Earlier rounds
- Pre-Seed: $2.7M
The numbers around it
Healthcare & Life Sciences in November 2026: 3 rounds with a disclosed amount, $5.3 million in all; the biggest was Venomics AI ($2.7M). Every sector this year →
Terms in this story
- Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
- Seed round: Pre-seed and seed are the first money a startup raises from outside investors. The difference is how much has been built when the cheque arrives: pre-seed backs an idea or prototype, usually with a cheque under ₹5 crore, while seed backs an early product and runs from a few crore rupees to a few million dollars.
Read next
FundingFroncort.AI gets $2.3M from Google.orgFroncort.AI is a Pune-based startup that builds artificial intelligence tools to help health teams spot and track disease outbreaks earlyNewsDoctors question Temple wearable's brain-flow claimsTemple makes a ₹85,000 wearable that tracks body signals, including blood flow near the head, and pairs the readings with AI insightsPeopleDeepinder Goyal to explain exit from EternalTemple is a startup building a small wearable that tracks blood flow to the brain and shows a live stress score
All startup news on 5 November 2026 →
Is this Venomics AI? Get your “Featured on StopDown” badge →